ONMDWNasdaqServices-Commercial Physical & Biological ResearchUS GAAP · USD

OneMedNet Corp

OneMedNet Corp is a U.S.-based commercial research services company focused on collecting, curating, and delivering medical imaging and related clinical data for research and analytics use. The company operates as a data-enabled services business serving healthcare, life sciences, and other research-oriented customers that need access to de-identified real-world medical data.

Revenue1.4m USD
+111.4 %y/y
Operating profit (EBIT)-9.7m USD
−0.6 %y/y
EBIT margin-711.3%
+782.4 ppy/y
Net income-2.8m USD
+72.3 %y/y
Free cash flow-7.5m USD
−7.3 %y/y

Fiscal year 2025 · change from previous year

Development 2021–2025

-10.0-7.5-5.0-2.50.02.5m USD2021: EBIT -0.59 m USD20212022: 1.2 m USD2022: EBIT -7.7 m USD20222023: 1.0 m USD2023: EBIT -6.9 m USD20232024: 0.64 m USD2024: EBIT -9.6 m USD20242025: 1.4 m USD2025: EBIT -9.7 m USD20251.4-9.7
RevenueOperating profit (EBIT)

Business

Share of revenue
Medical imaging data services45 %

Collection, organization, and delivery of imaging data for research and analytics use.

Clinical data curation30 %

De-identification and structuring of clinical records and related metadata.

Data licensing15 %

Licensing curated datasets to customers for research, model development, and analysis.

Research support services10 %

Project support, data preparation, and related services for research workflows.

Products

Reported · share of revenue
92.3%FY2025100 %
  • Data Delivery Revenue92.3 %
  • Subscription Revenue7.7 %

Source: 10-K FY2025, revenue the company reports per product line (SEC XBRL). Shares are of the lines shown and add up to 100 %.

Customers

OneMedNet’s customers are typically organizations that need high-quality medical data for research, analytics, and product development. These buyers include life sciences companies, healthcare technology firms, and research institutions that value curated, de-identified datasets and the ability to use them in regulated workflows.

Life sciences companies

Buy curated medical data and research support for evidence generation and development programs.

Healthcare technology companies

Use de-identified imaging and clinical data to train, validate, and commercialize analytics tools.

Research institutions

Purchase or access datasets for academic, translational, and clinical research projects.

Healthcare providers and networks

May contribute data or engage for research-oriented data services and collaborations.

Strategy

The company’s strategy is to expand the utility of its medical data platform by increasing the volume, quality, and usability of curated datasets. It also depends on building customer relationships in research and analytics markets where differentiated data access can support recurring demand and broader use cases.

Grow the curated data asset baseMedium term

More and better data increases the platform’s value to research customers.

Deepen customer adoption in research marketsMedium term

Repeat usage and broader customer penetration support commercialization.

Maintain compliance and data governanceShort term

Healthcare data businesses depend on privacy, consent, and regulatory trust.

Geography

OneMedNet is headquartered in the United States and its business is centered on U.S. healthcare data and research markets. Its operating footprint is tied to access to clinical data sources, healthcare providers, and research customers, so regulatory and data-governance requirements in the U.S. are central to the business.

Risks

The business depends on access to regulated healthcare data, so privacy, consent, and data-governance failures could materially disrupt operations. It also faces commercialization risk because demand depends on customers’ willingness to adopt curated datasets and on the company’s ability to maintain a differentiated data supply.

Sorted by severity
Healthcare privacy and regulatory complianceHigh

The company handles sensitive medical data and must meet privacy and de-identification requirements.

ExposureData collectionCurationLicensing workflows
Data supply concentration and access riskHigh

The platform depends on continued access to clinical data sources and contributors.

Exposure: Provider relationships and data ingestion

Commercial adoption riskMedium

Customers must see enough value in the datasets to renew or expand usage.

Exposure: Life sciences and healthcare analytics demand

Competition and substitutionMedium

Other data vendors or internal customer data assets can reduce demand for the company’s offerings.

Exposure: Research data licensing market

Accounting

Judgemental items
Revenue recognition

Data licensing and research services may have different timing rules depending on contract terms.

Impact: Can shift revenue between periods and affect comparability.

Contract assets and receivables

Customer billing may not align with service delivery or access periods.

Impact: Affects working capital and credit-loss estimates.

Intangible asset and software impairment

Platform-related assets require judgment on future recoverability.

Impact: Can create non-cash charges if expected cash flows weaken.

Publicly listed companies with a comparable business focus.

Last updated: 24/09/2026

OneMedNet Corp (ONMDW) Revenue, Earnings & Financials 2025 – Clarifo